Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey

Detalhes bibliográficos
Autor(a) principal: Revés, Joana Branco
Data de Publicação: 2021
Outros Autores: Frias-Gomes, Catarina, Morão, Bárbara, Nascimento, Catarina, Palmela, Carolina, Fidalgo, Catarina, Roque Ramos, Lídia, Sampaio, Ana, Glória, Luísa, Cravo, Marília, Torres, Joana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/53260
Resumo: © 2021 Sociedade Portuguesa de Gastrenterologia. Published by S. Karger AG, BaselThis is an Open Access article licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense), applicable to the online version of the article only. Usage and distribution for com- mercial purposes requires written permission
id RCAP_d7531a6531f35b46b2d64320b58bdd1a
oai_identifier_str oai:repositorio.ul.pt:10451/53260
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese surveyCOVID-19Crohn's diseaseInflammatory bowel diseaseUlcerative colitis© 2021 Sociedade Portuguesa de Gastrenterologia. Published by S. Karger AG, BaselThis is an Open Access article licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense), applicable to the online version of the article only. Usage and distribution for com- mercial purposes requires written permissionIntroduction: Patients with inflammatory bowel disease (IBD) do not seem to be at increased risk of infection by SARS-CoV-2, but there is a concern whether immunosuppressive therapy may be associated with more severe disease. Several clinical practice recommendations have been published to help guide IBD care during the COVID-19 pandemic. Nonetheless, few studies have addressed patients' perspectives and fears. We aimed to evaluate Portuguese IBD patients' perspectives on the clinical management of their disease during the SARS-CoV-2 pandemic as well as the impact on their professional life. Methods: An anonymous electronic survey was created using REDCap and was distributed by the Portuguese Association of Inflammatory Bowel Disease (APDI) between May and August 2020. Patients' perspectives on immunosuppressive therapy, disease management, interaction with gastroenterology departments, and the impact of the pandemic in their professional life were assessed. Patients' proposals to improve medical care were also evaluated. Descriptive analysis and logistic regression were performed. Results: A total of 137 participants answered the survey (79.6% females, mean age 41.7 ± 12.1 years). Although having IBD and receiving treatment with immunosuppressors (thiopurines, steroids, or biologics) were considered promotors of anxiety, most patients (85.4%) agreed that disease remission was a priority and only a minority of patients interrupted their treatment during the pandemic. In multivariate analysis, active disease, biologic treatment, and use of corticosteroids in the last 3 months were perceived by the patients as high-risk features for increased risk of SARS-Cov-2 infection and more severe disease. Fifty-nine patients (44%) believed that their follow-up was influenced by the pandemic and only 58.8% felt that they had the opportunity to discuss their therapeutic options with their doctor. Sixty-three patients (46.0%) were working from home during the pandemic, although this decision was related to IBD and immunosuppressive therapy in only 36.5 and 39.7% of the cases, respectively. Areas where care could have been improved during the pandemic were identified by patients, namely enhancement of the communication with IBD professionals, conciliation of telemedicine with face-to-face appointments, and facilitation of the interaction between patients and employers. Conclusion: Most patients agreed that maintaining IBD remission is crucial, and only a minority of the patients stopped their treatment as per their own initiative. IBD status only had a small influence on patients' professional activity during the COVID-19 outbreak, with most changes being related to the pandemic itself.KargerRepositório da Universidade de LisboaRevés, Joana BrancoFrias-Gomes, CatarinaMorão, BárbaraNascimento, CatarinaPalmela, CarolinaFidalgo, CatarinaRoque Ramos, LídiaSampaio, AnaGlória, LuísaCravo, MaríliaTorres, Joana2022-06-01T16:03:55Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/53260engGE Port J Gastroenterol. 2021 Sep 16;5:1-92341-454510.1159/0005189452387-1954info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:58:57Zoai:repositorio.ul.pt:10451/53260Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:04:14.523935Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
title Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
spellingShingle Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
Revés, Joana Branco
COVID-19
Crohn's disease
Inflammatory bowel disease
Ulcerative colitis
title_short Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
title_full Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
title_fullStr Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
title_full_unstemmed Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
title_sort Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
author Revés, Joana Branco
author_facet Revés, Joana Branco
Frias-Gomes, Catarina
Morão, Bárbara
Nascimento, Catarina
Palmela, Carolina
Fidalgo, Catarina
Roque Ramos, Lídia
Sampaio, Ana
Glória, Luísa
Cravo, Marília
Torres, Joana
author_role author
author2 Frias-Gomes, Catarina
Morão, Bárbara
Nascimento, Catarina
Palmela, Carolina
Fidalgo, Catarina
Roque Ramos, Lídia
Sampaio, Ana
Glória, Luísa
Cravo, Marília
Torres, Joana
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Revés, Joana Branco
Frias-Gomes, Catarina
Morão, Bárbara
Nascimento, Catarina
Palmela, Carolina
Fidalgo, Catarina
Roque Ramos, Lídia
Sampaio, Ana
Glória, Luísa
Cravo, Marília
Torres, Joana
dc.subject.por.fl_str_mv COVID-19
Crohn's disease
Inflammatory bowel disease
Ulcerative colitis
topic COVID-19
Crohn's disease
Inflammatory bowel disease
Ulcerative colitis
description © 2021 Sociedade Portuguesa de Gastrenterologia. Published by S. Karger AG, BaselThis is an Open Access article licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense), applicable to the online version of the article only. Usage and distribution for com- mercial purposes requires written permission
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
2022-06-01T16:03:55Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/53260
url http://hdl.handle.net/10451/53260
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv GE Port J Gastroenterol. 2021 Sep 16;5:1-9
2341-4545
10.1159/000518945
2387-1954
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Karger
publisher.none.fl_str_mv Karger
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134593075380224

Registros relacionados